AAVs are currently gaining importance in gene therapy for the delivery of genetic material into the cell. AAV will cause no viral disease symptoms in the target organism, and only a mild immune response is to be expected. Integration into the host genome as achieved by transfection with lentiviral vectors (LV) is extremely rare.